ATAsye Ceren Tanritanir

Asye Ceren Tanritanir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Asye Ceren Tanritanir has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Alexa Craig

    Department of Pediatrics, Maine Medical Center, ME, USA

    1 shared publication
  • Borjan Gagoski

    Fetal Neonatal Neuroimaging and Developmental Science Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA

    1 shared publication
  • Caitlin K. Rollins

    Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA

    1 shared publication
  • Cynthia Ortinau

    Department of Pediatrics Newborn Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

    1 shared publication
  • David S. Newburg

    Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH

    1 shared publication
  • Diana W. Bianchi

    Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA

    1 shared publication

Latest Publications

  • Disorganized Patterns of Sulcal Position in Fetal Brains with Agenesis of Corpus Callosum

    by Tomo Tarui, Neel Madan, Nabgha Farhat, Rie Kitano, Asye Ceren Tanritanir, George Graham, Borjan Gagoski, Alexa Craig, Caitlin K. Rollins, Cynthia Ortinau, et al.

    Fetuses with isolated agenesis of the corpus callosum (ACC) are associated with a broad spectrum of neurodevelopmental disability that cannot be specifically predicted in prenatal neuroimaging. We hypothesized that ACC may be associated with aberrant cortical folding. In this study, we determined altered patterning of early primary sulci development in fetuses with isolated ACC using novel quantitative sulcal pattern analysis which measures deviations of regional sulcal features (position, depth, and area) and their intersulcal relationships in 7 fetuses with isolated ACC (27.1 ± 3.8 weeks of gestation, mean ± SD) and 17 typically developing (TD) fetuses (25.7 ± 2.0 weeks) from normal templates. Fetuses with ACC showed significant alterations in absolute sulcal positions and relative intersulcal positional relationship compared to TD fetuses, which were not detected by traditional gyrification index. Our results reveal altered sulcal positional development even in isolated ACC that is present as early as the second trimester and continues throughout the fetal period. It might originate from altered white matter connections and portend functional variances in later life.


  • Lactodifucotetraose, a human milk oligosaccharide, attenuates platelet function and inflammatory cytokine release

    by David S. Newburg, Ayse C. Tanritanir, Subrata Chakrabarti

    Human milk strongly quenches inflammatory processes in vitro, and breastfed infants have lower incidence of inflammatory diseases than those fed artificially. Platelets from neonates, in contrast to those from adults, are less responsive to platelet agonists such as collagen, thrombin, ADP, and epinephrine. Breastfed infants absorb oligosaccharides intact from the human milk in their gut to the circulation. This study was to determine whether these oligosaccharides can attenuate platelet function and platelet secretion of pro-inflammatory proteins, and to identify the active component. The natural mixture of oligosaccharides from human milk and pure individual human milk oligosaccharides were tested for their ability to modulate responses of platelets isolated from human blood following exposure to thrombin, ADP, and collagen. Human milk and the natural mixture of human milk oligosaccharides inhibited platelet release of inflammatory proteins. Of the purified human milk oligosaccharides tested, only lactodifucotetraose (LDFT) significantly inhibited thrombin induced release of the pro-inflammatory proteins RANTES and sCD40L. LDFT also inhibited platelet adhesion to a collagen-coated surface, as well as platelet aggregation induced by ADP or collagen. These data indicate that LDFT may help modulate hemostasis by suppressing platelet-induced inflammatory processes in breastfed infants. This activity suggests further study of LDFT for its potential as a therapeutic agent in infants and adults.